Rayno Biopharmaceutical Stocks Up Big in Q1
No changes have been made in our core portfolio positions except as noted below. But given the YTD run no new positions should be added. Look for a sector driver 2-3 weeks before the ASCO Annual Meeting on May 31. Our index of 35 mid-cap biopharmaceutical stocks shows a lot of red and 4 significant green stocks: ALKS,ARRY,INFN,THLD. Array (NASDAQ:ARRY) was upgraded by Piper Jaffray yesterday and the chart looks good and has 3 drugs in its product pipeline.
Action today with strong charts since Feb. 26 Sell-Off
ALXN ($91.6) stable and recovering off 1 month lows
BIIB ($176) solid performer up 8% since Feb. 25
GILD ($45.47) solid performer up 6.7% since Feb. 25
IMGN ($15.39) solid performer up 8.6% since Feb. 25
PCYC ($79.13) losing MO, off 12% in 5 days
REGN ($169.6) stable and recovering off 1 month lows
SGEN ($36) solid performer up 30.4 % since Feb. 25
Portfolio Updates-See Original Posts
New Long: Achillion (ACHN $8.67) added at $8.60 for HCV play
Infinity got a big 5% boost today in an article in MarketWatch that focuses on the technicals of INFI.
IBB is near recent highs after 3%+ breakout
Disclosure: I am long ACHN.